DocuSign CRO Paula Hansen sells $227,061 in company stock
DocuSign CRO Paula Hansen sold 3,300 shares of DOCU stock on October 1, 2026, totaling $227,061. The sales were part of a 10b5-1 plan. DOCU shares have risen 43% in six months, trading near a 52-week high. Analysts have mixed price targets, with some seeing undervaluation and others focusing on IAM growth. The company reported strong Q2 revenue growth and raised fiscal 2027 targets.
How this was made
The 30-second read
Why it matters
The insider sale is a minor data point amid overall positive momentum.
Market read
While the insider sale is routine, it adds a small data point for traders monitoring insider activity.
What to watch
Recent strong quarterly results and analyst upgrades may offset any sell‑off pressure.
Background
DocuSign reported strong Q2 results and raised targets, leading to analyst price target upgrades.
Ticker impact
Form 4 filing shows CRO Paula Hansen sold 3,300 shares for $227,061, a routine insider sale.
potential slight downward pressure as market prices in insider selling
The sale is modest in size and follows a 10b5-1 plan; no material change to fundamentals.
Market effects
Minimal impact on the broader e‑signature sector.
No significant regional effect.
Limited global relevance.
Counterpoint
The sale could be a routine liquidity event, not a negative signal.
Key entities
- ExecutivePaula Hansen
Chief Revenue Officer of DocuSign


